Tag: cytokine release syndrome

Mount Sinai Study Uncovers Inflammatory Markers that May Predict a Response in Certain Patients to COVID-19 Immunotherapies

sarah JonasResearch Results

Researchers at The Tisch Cancer Institute uncovered inflammatory markers that may predict which COVID-19 patients are more likely to respond to therapies like the anti-cancer drug pacritinib, according to phase 2 trial results published in JAMA Network Open in December.

Moffitt Researchers Identify Factors to Predict Severe Toxicities in CAR T Patients

sarah JonasResearch Results

In a new study published in Clinical Cancer Research, Moffitt Cancer Center researchers identify possible factors that could help physicians know if patients are at higher risk for severe adverse events before they receive CAR T therapy.